iFOREX Adds the CAC 40 Index to its Global Trading Platform
Leading online currency trading company iFOREX has recently diversified its list of tradable products by introducing the CAC 40 index. Traders can now enjoy the CAC 40 Contract for Difference, alongside other tradable products such as oil, gold, currencies and other indices. Clients of iFOREX can easily access CFD trading in an array of languages, including Italian, Spanish and French which can be found at http://www.iforex.it , http://www.iforex.es and http://www.iforex.fr
For traders who want to diversify their portfolio with market indices, the European CAC 40 can be a smart place to start. The CAC 40 represents the various economic sectors quoted on the Euronext Paris market by comprising the major 40 stocks, based on market capitalization. The index is commonly known to be reliable due to its regular trends and relatively low volatility, thus making the index a main benchmark for Euronext Paris.
When asked about the new addition of the CAC 40 index to the list of tradable CFDs, a senior marketing executive was quoted saying, “We are excited to offer the CAC 40 index to all of our traders at iFOREX through our online trading platform. The new addition of this index into our list of tradable CFDs is a great advantage for our clients, as it provides the opportunity to benefit from the European index’s movements and diversify one’s trading portfolio.”
iFOREX strives to stay at the forefront of CFD trading by continuously introducing new and advanced tradable products into its platform. For direct information about CFD trading and the services iFOREX provides, visit http://www.iforex.com .
*Leveraged Forex/CFD trading involves considerable risk. Territorial restrictions may apply.
The English-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the English-language text, which is the only version of the text intended to have legal effect.
Contact:
iFOREX (Cyprus) Ltd.
Olga Lampadaridou
Head of
Investment Research Department
+357-252-04600
pr@iforex.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Raises the Bar for Workforce Development With State-of-the-Art Career & Learning Center23.4.2025 22:00:00 CEST | Press release
Textron Aviation Inc. a Textron Inc. (NYSE: TXT) company, today announced its new Career & Learning Center is complete and fully operational serving prospective, current and future Textron Aviation employees. Strategically located on the company’s East Wichita Campus, this state-of-the-art facility expands the training footprint to more than 75,000 square feet and provides a world-class employee experience during the application, hiring, onboarding and training processes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423874476/en/ Textron Aviation Career and Learning Center | Textron Aviation “The Textron Aviation Career & Learning Center is an important investment in building the next generation of aviation manufacturing, support and professional talent,” said Ron Draper, president and CEO. “Recruiting, hiring and training a world-class workforce is vital to our ability to provide the best aviation experience for our cu
TSMC Unveils Next-Generation A14 Process at North America Technology Symposium23.4.2025 20:40:00 CEST | Press release
Showcasing TSMC’s latest offerings for high performance computing, smartphone, automotive, and IoT applications TSMC (TWSE: 2330, NYSE: TSM) today unveiled its next cutting-edge logic process technology, A14, at the Company’s North America Technology Symposium. Representing a significant advancement from TSMC’s industry-leading N2 process, A14 is designed to drive AI transformation forward by delivering faster computing and greater power efficiency. It is also expected to enhance smartphones by improving their on-board AI capabilities, making them even smarter. Planned to enter production in 2028, the current A14 development is progressing smoothly with yield performance ahead of schedule. Compared with the N2 process, which is about to enter volume production later this year, A14 will offer up to 15% speed improvement at the same power, or up to 30% power reduction at the same speed, along with more than 20% increase in logic density. Leveraging the Company’s experience in design-tech
Veracode Delivers End-to-End Risk Coverage with New Tools: AI-Powered Dynamic Analysis Security Testing with External Attack Surface Management23.4.2025 17:42:00 CEST | Press release
Seamless Integration and Speed: Latest Innovations Empower Faster, Smarter, and Safer Software Security Veracode, a global leader in application risk management, today announced new capabilities to help organizations address emerging threats, giving security professionals better visibility and control in one place. The launch includes new AI-powered functionality in the Dynamic Application Security Testing (DAST)product and an External Attack Surface Management (EASM) capability. Together, they enable security teams to discover their entire attack surface and prioritize the most critical risk to streamline and simplify security scanning. “Security teams need to see and secure everything; not only what is inside their perimeter,” said Derek Maki, Head of Product at Veracode. “With our latest DAST capabilities and Application Risk Management platform enhancements, we’re helping organizations shift from vulnerability scanning to holistic risk management, to better identify risk residing i
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting23.4.2025 17:03:00 CEST | Press release
Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30 – June 3, 2025, in Chicago. “The data featured at the 2025 ASCO Annual Meeting, from both our approved medicines and early-stage pipeline, reflect our ongoing efforts to transform cancer care,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “We are advancing potential therapies across some of the most difficult-to-treat cancers and hematological diseases, including squamous cell anal cancer, ovarian cancer and myelofibrosis, with the hope of making a meaningful difference for these patients.” Key abstracts accepted for presentation: Oral Presentations INCB123667 Safety and Preliminary Efficacy from a Phase 1 Study of INCB123667, a Selective CDK2 Inhibitor, in Patients with Advanced Platinum-Resistant and Refractory Ovarian Cancer (OC) (Abst
LTIMindtree’s FY25 Revenue up 7% in INR23.4.2025 16:42:00 CEST | Press release
Order Inflow at USD 6 Billion, up 6% on full-year basis LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended Mar 31, 2025, as approved by its Board of Directors. “We concluded FY25 with a revenue growth of 5% in constant currency terms and an EBIT margin of 14.5%. Our key verticals and a major geography drove our yearly growth despite an ongoing challenging macro environment. The robust order inflow, driven by a significant array of AI-led deal wins, illustrates the pervasive integration of AI across our service offerings. Venu Lambu’s transition to LTIMindtree has been seamless and supports our strategic goals. His growing understanding of the organisation, combined with our ability to secure large deals, strong presence in tech-intensive sectors, and robust balance sheet, positions us well to leverage the opportunities ahead of us.” - Debashis Chatterjee,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom